Inhibition of Wild-Type P53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0429
Full Text
Open PDFAbstract
Available in full text
Date
July 23, 2015
Authors
Publisher
American Association for Cancer Research (AACR)